ASX - By Stock
|
ACR |
Axiron Earnings - USD 36.8m
|
|
mita
|
2 |
1.3K |
3 |
25/07/17 |
25/07/17 |
ASX - By Stock
|
2
|
1.3K
|
3
|
|
ASX - By Stock
|
ACR |
Re:
Ann: Change in substantial holding
|
|
mita
|
5 |
2.8K |
0 |
01/02/17 |
01/02/17 |
ASX - By Stock
|
5
|
2.8K
|
0
|
|
ASX - By Stock
|
ACR |
Re:
Historical prediction
|
|
mita
|
61 |
22K |
1 |
01/02/17 |
01/02/17 |
ASX - By Stock
|
61
|
22K
|
1
|
|
ASX - By Stock
|
ACR |
Re:
Historical prediction
|
|
mita
|
61 |
22K |
2 |
01/02/17 |
01/02/17 |
ASX - By Stock
|
61
|
22K
|
2
|
|
ASX - By Stock
|
ACR |
Re:
Historical prediction
|
|
mita
|
61 |
22K |
1 |
01/02/17 |
01/02/17 |
ASX - By Stock
|
61
|
22K
|
1
|
|
ASX - By Stock
|
ACR |
Re:
Historical prediction
|
|
mita
|
61 |
22K |
0 |
01/02/17 |
01/02/17 |
ASX - By Stock
|
61
|
22K
|
0
|
|
ASX - By Stock
|
ACR |
Re:
Historical prediction
|
|
mita
|
61 |
22K |
0 |
31/01/17 |
31/01/17 |
ASX - By Stock
|
61
|
22K
|
0
|
|
ASX - By Stock
|
ACR |
Re:
Historical prediction
|
|
mita
|
61 |
22K |
3 |
30/01/17 |
30/01/17 |
ASX - By Stock
|
61
|
22K
|
3
|
|
ASX - By Stock
|
ACR |
Re:
Ann: IPR Petition Filed Against Key Jublia Patent-ACR.AX
|
|
mita
|
5 |
2.1K |
1 |
03/11/16 |
03/11/16 |
ASX - By Stock
|
5
|
2.1K
|
1
|
|
ASX - By Stock
|
ACR |
Re:
Ann: IPR Petition Filed Against Key Jublia Patent-ACR.AX
|
|
mita
|
5 |
2.1K |
1 |
03/11/16 |
03/11/16 |
ASX - By Stock
|
5
|
2.1K
|
1
|
|
ASX - By Stock
|
ACR |
Re:
Ann: NEW INTELLECTUAL PROPERTY APPLICATION FOR ONYCHOMYCOSIS-ACR.AX
|
|
mita
|
4 |
1.8K |
3 |
02/11/16 |
02/11/16 |
ASX - By Stock
|
4
|
1.8K
|
3
|
|
ASX - By Stock
|
ACR |
Re:
$39 for q3 - not bad, considering
|
|
mita
|
13 |
4.0K |
1 |
01/11/16 |
01/11/16 |
ASX - By Stock
|
13
|
4.0K
|
1
|
|
ASX - By Stock
|
ACR |
Re:
$39 for q3 - not bad, considering
|
|
mita
|
13 |
4.0K |
2 |
26/10/16 |
26/10/16 |
ASX - By Stock
|
13
|
4.0K
|
2
|
|
ASX - By Stock
|
ACR |
Re:
$39 for q3 - not bad, considering
|
|
mita
|
13 |
4.0K |
3 |
26/10/16 |
26/10/16 |
ASX - By Stock
|
13
|
4.0K
|
3
|
|
ASX - By Stock
|
ACR |
Re:
$39 for q3 - not bad, considering
|
|
mita
|
13 |
4.0K |
4 |
26/10/16 |
26/10/16 |
ASX - By Stock
|
13
|
4.0K
|
4
|
|
ASX - By Stock
|
ACR |
$39 for q3 - not bad, considering
|
|
mita
|
13 |
4.0K |
4 |
26/10/16 |
26/10/16 |
ASX - By Stock
|
13
|
4.0K
|
4
|
|
ASX - By Stock
|
ACR |
Re:
Technicals
|
|
mita
|
30 |
9.0K |
2 |
27/09/16 |
27/09/16 |
ASX - By Stock
|
30
|
9.0K
|
2
|
|
ASX - By Stock
|
ACR |
Re:
ACR
|
|
mita
|
5 |
1.4K |
2 |
25/08/16 |
25/08/16 |
ASX - By Stock
|
5
|
1.4K
|
2
|
|
ASX - By Stock
|
ACR |
Re:
Ann: Acrux announces 2016 financial results-ACR.AX
|
|
mita
|
29 |
6.7K |
0 |
25/08/16 |
25/08/16 |
ASX - By Stock
|
29
|
6.7K
|
0
|
|
ASX - By Stock
|
ACR |
Re:
Ann: Acrux announces 2016 financial results-ACR.AX
|
|
mita
|
29 |
6.7K |
1 |
25/08/16 |
25/08/16 |
ASX - By Stock
|
29
|
6.7K
|
1
|
|
ASX - By Stock
|
ACR |
Re:
Ann: Acrux announces 2016 financial results-ACR.AX
|
|
mita
|
29 |
6.7K |
0 |
25/08/16 |
25/08/16 |
ASX - By Stock
|
29
|
6.7K
|
0
|
|
ASX - By Stock
|
ACR |
Re:
Ann: Acrux announces 2016 financial results-ACR.AX
|
|
mita
|
29 |
6.7K |
1 |
25/08/16 |
25/08/16 |
ASX - By Stock
|
29
|
6.7K
|
1
|
|
ASX - By Stock
|
ACR |
Re:
Ann: Acrux and Eli Lilly to appeal patent ruling on Axiron-ACR.AX
|
|
mita
|
28 |
7.0K |
4 |
24/08/16 |
24/08/16 |
ASX - By Stock
|
28
|
7.0K
|
4
|
|
ASX - By Stock
|
ACR |
Re:
Ann: Acrux and Eli Lilly to appeal patent ruling on Axiron-ACR.AX
|
|
mita
|
28 |
7.0K |
4 |
24/08/16 |
24/08/16 |
ASX - By Stock
|
28
|
7.0K
|
4
|
|
ASX - By Stock
|
ACR |
Re:
Ann: Acrux and Eli Lilly to appeal patent ruling on Axiron-ACR.AX
|
|
mita
|
28 |
7.0K |
1 |
24/08/16 |
24/08/16 |
ASX - By Stock
|
28
|
7.0K
|
1
|
|
ASX - By Stock
|
ACR |
Re:
Ann: Acrux and Eli Lilly to appeal patent ruling on Axiron-ACR.AX
|
|
mita
|
28 |
7.0K |
2 |
24/08/16 |
24/08/16 |
ASX - By Stock
|
28
|
7.0K
|
2
|
|
ASX - By Stock
|
ACR |
Re:
Ann: Acrux announces court ruling on Axiron patent families-ACR.AX
|
|
mita
|
92 |
25K |
1 |
24/08/16 |
24/08/16 |
ASX - By Stock
|
92
|
25K
|
1
|
|
ASX - By Stock
|
ACR |
Re:
Ann: Acrux and Eli Lilly to appeal patent ruling on Axiron-ACR.AX
|
|
mita
|
28 |
7.0K |
0 |
24/08/16 |
24/08/16 |
ASX - By Stock
|
28
|
7.0K
|
0
|
|
ASX - By Stock
|
ACR |
Re:
Ann: Acrux and Eli Lilly to appeal patent ruling on Axiron-ACR.AX
|
|
mita
|
28 |
7.0K |
0 |
24/08/16 |
24/08/16 |
ASX - By Stock
|
28
|
7.0K
|
0
|
|
ASX - By Stock
|
ACR |
Re:
Ann: Acrux and Eli Lilly to appeal patent ruling on Axiron-ACR.AX
|
|
mita
|
28 |
7.0K |
2 |
24/08/16 |
24/08/16 |
ASX - By Stock
|
28
|
7.0K
|
2
|
|
ASX - By Stock
|
ACR |
Re:
Ann: Acrux announces court ruling on Axiron patent families-ACR.AX
|
|
mita
|
92 |
25K |
0 |
24/08/16 |
24/08/16 |
ASX - By Stock
|
92
|
25K
|
0
|
|
ASX - By Stock
|
ACR |
Re:
Ann: Acrux announces court ruling on Axiron patent families-ACR.AX
|
|
mita
|
92 |
25K |
0 |
24/08/16 |
24/08/16 |
ASX - By Stock
|
92
|
25K
|
0
|
|
ASX - By Stock
|
ACR |
Re:
Ann: Acrux announces court ruling on Axiron patent families-ACR.AX
|
|
mita
|
92 |
25K |
0 |
24/08/16 |
24/08/16 |
ASX - By Stock
|
92
|
25K
|
0
|
|
ASX - By Stock
|
ACR |
Re:
Ann: Acrux announces court ruling on Axiron patent families-ACR.AX
|
|
mita
|
92 |
25K |
1 |
23/08/16 |
23/08/16 |
ASX - By Stock
|
92
|
25K
|
1
|
|
ASX - By Stock
|
ACR |
Re:
Ann: Acrux announces court ruling on Axiron patent families-ACR.AX
|
|
mita
|
92 |
25K |
0 |
23/08/16 |
23/08/16 |
ASX - By Stock
|
92
|
25K
|
0
|
|
ASX - By Stock
|
ACR |
Re:
Ann: Acrux announces court ruling on Axiron patent families-ACR.AX
|
|
mita
|
92 |
25K |
3 |
23/08/16 |
23/08/16 |
ASX - By Stock
|
92
|
25K
|
3
|
|
ASX - By Stock
|
ACR |
Re:
Ann: Acrux announces court ruling on Axiron patent families-ACR.AX
|
|
mita
|
92 |
25K |
0 |
23/08/16 |
23/08/16 |
ASX - By Stock
|
92
|
25K
|
0
|
|
ASX - By Stock
|
ACR |
Re:
Ann: Acrux announces court ruling on Axiron patent families-ACR.AX
|
|
mita
|
92 |
25K |
4 |
23/08/16 |
23/08/16 |
ASX - By Stock
|
92
|
25K
|
4
|
|
ASX - By Stock
|
ACR |
Re:
Ann: Acrux announces court ruling on Axiron patent families-ACR.AX
|
|
mita
|
92 |
25K |
2 |
23/08/16 |
23/08/16 |
ASX - By Stock
|
92
|
25K
|
2
|
|
ASX - By Stock
|
ACR |
Re:
Ann: Acrux announces court ruling on Axiron patent families-ACR.AX
|
|
mita
|
92 |
25K |
6 |
23/08/16 |
23/08/16 |
ASX - By Stock
|
92
|
25K
|
6
|
|
ASX - By Stock
|
ACR |
Re:
Ann: Acrux announces court ruling on Axiron patent families-ACR.AX
|
|
mita
|
92 |
25K |
1 |
23/08/16 |
23/08/16 |
ASX - By Stock
|
92
|
25K
|
1
|
|
ASX - By Stock
|
ACR |
Re:
Ann: Acrux announces court ruling on Axiron patent families-ACR.AX
|
|
mita
|
92 |
25K |
0 |
23/08/16 |
23/08/16 |
ASX - By Stock
|
92
|
25K
|
0
|
|
ASX - By Stock
|
ACR |
Re:
Ann: Acrux announces court ruling on Axiron patent families-ACR.AX
|
|
mita
|
92 |
25K |
8 |
23/08/16 |
23/08/16 |
ASX - By Stock
|
92
|
25K
|
8
|
|
ASX - By Stock
|
ACR |
Re:
Ann: Acrux announces court ruling on Axiron patent families-ACR.AX
|
|
mita
|
92 |
25K |
2 |
23/08/16 |
23/08/16 |
ASX - By Stock
|
92
|
25K
|
2
|
|
ASX - By Stock
|
ACR |
Re:
Ann: Acrux announces court ruling on Axiron patent families-ACR.AX
|
|
mita
|
92 |
25K |
2 |
23/08/16 |
23/08/16 |
ASX - By Stock
|
92
|
25K
|
2
|
|
ASX - By Stock
|
ACR |
Re:
Ann: Acrux announces court ruling on Axiron patent families-ACR.AX
|
|
mita
|
92 |
25K |
1 |
23/08/16 |
23/08/16 |
ASX - By Stock
|
92
|
25K
|
1
|
|
ASX - By Stock
|
ACR |
Re:
Ann: Acrux announces court ruling on Axiron patent families-ACR.AX
|
|
mita
|
92 |
25K |
2 |
23/08/16 |
23/08/16 |
ASX - By Stock
|
92
|
25K
|
2
|
|
ASX - By Stock
|
ACR |
Re:
Trt market trends
|
|
mita
|
3 |
1.2K |
2 |
09/08/16 |
09/08/16 |
ASX - By Stock
|
3
|
1.2K
|
2
|
|
ASX - By Stock
|
ACR |
Trt market trends
|
|
mita
|
3 |
1.2K |
2 |
09/08/16 |
09/08/16 |
ASX - By Stock
|
3
|
1.2K
|
2
|
|
ASX - By Stock
|
ACR |
Re:
Broker Views
|
|
mita
|
6 |
2.0K |
3 |
01/08/16 |
01/08/16 |
ASX - By Stock
|
6
|
2.0K
|
3
|
|